Washington: Last News

CDC panel OKs Pfizer booster for 65 and older, others at high risk

WASHINGTON - An advisory panel for the U.S. Centers for Disease Control and Prevention granted its final approval on Thursday for offering booster doses of Pfizer’s COVID-19 vaccine to Americans ages 65 and up and others at high risk for severe disease, clearing the way for the extra shots to begin. The advisory panel to the CDC recommended the extra doses for people 65 and older, nursing home residents, and people who are 50 to 64 with underlying medical conditions.

It also said boosters can be offered to people 18 to 49 with underlying conditions.The shots would be given at least six months after the second dose of the Pfizer vaccine.CDC Director Dr. Rochelle Walensky must next sign off on the recommendation.

covid-19 vaccine Health

Rochelle Walensky

www.fox29.comwww.fox29.com

Washington: Main News

WASHINGTON - An advisory panel for the U.S. Centers for Disease Control and Prevention granted its final approval on Thursday for offering booster doses of Pfizer’s COVID-19 vaccine to Americans ages 65 and up and others at high risk for severe disease, clearing the way for the extra shots to begin. The advisory panel to the CDC recommended the extra doses for people 65 and older, nursing home residents, and people who are 50 to 64 with underlying medical conditions.
WASHINGTON - The number of Americans applying for unemployment aid rose last week for a second straight week to 351,000, a sign that the delta variant of the coronavirus may be disrupting the job market's recovery, at least temporarily.Thursday's report from the Labor Department showed that jobless claims rose by 16,000 from the previous week.

Related News